As many as 9.6 million people die every year from cancer. Cancer does not all have the same cause, which means treatments and types of medicines differ accordingly. While the demand for medicinal supplies is increasing, they may also contain hazardous substances, making them difficult to handle. The OEE German team has developed highly adaptable testing solution technology that controls the quality of each drug production line in order to provide patients with optimal treatment according to the type of cancer they have. This makes it possible to inspect the quality at every stage of the manufacturing process. Providing this testing solution enables us to decrease the risk of cancer and contribute to the healthy lives of people.